{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:55:32Z","timestamp":1791276932907,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":798,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1038\/mt.2014.84","type":"journal-article","created":{"date-parts":[[2014,5,12]],"date-time":"2014-05-12T07:19:25Z","timestamp":1399879165000},"page":"1450-1459","source":"Crossref","is-referenced-by-count":50,"title":["Systemic Administration of a Recombinant AAV1 Vector Encoding IGF-1 Improves Disease Manifestations in SMA Mice"],"prefix":"10.1016","volume":"22","author":[{"given":"Li-Kai","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Hung","family":"Ting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Lin-Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuh-Liang","family":"Hwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C","family":"Dodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco A","family":"Passini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seng H","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2014.84_bib1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/jmg.26.12.761","article-title":"A hungarian study on Werdnig-Hoffmann disease","volume":"26","author":"Czeizel","year":"1989","journal-title":"J Med Genet"},{"key":"10.1038\/mt.2014.84_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"10.1038\/mt.2014.84_bib3","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9","article-title":"An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA)","volume":"15","author":"Wirth","year":"2000","journal-title":"Hum Mutat"},{"key":"10.1038\/mt.2014.84_bib4","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1089\/ars.2008.2161","article-title":"The insulin-like growth factor family: molecular mechanisms, redox regulation, and clinical implications","volume":"11","author":"Vardatsikos","year":"2009","journal-title":"Antioxid Redox Sign"},{"key":"10.1038\/mt.2014.84_bib5","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/nn1789","article-title":"IGF-I specifically enhances axon outgrowth of corticospinal motor neurons","volume":"9","author":"Ozdinler","year":"2006","journal-title":"Nat Neurosci"},{"key":"10.1038\/mt.2014.84_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/17482960802160370","article-title":"Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosis","volume":"10","author":"Sakowski","year":"2009","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1038\/mt.2014.84_bib7","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.1086137","article-title":"Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model","volume":"301","author":"Kaspar","year":"2003","journal-title":"Science"},{"key":"10.1038\/mt.2014.84_bib8","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.neuron.2009.07.019","article-title":"Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy","volume":"63","author":"Palazzolo","year":"2009","journal-title":"Neuron"},{"key":"10.1038\/mt.2014.84_bib9","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1093\/hmg\/ddr067","article-title":"Increased IGF-1 in muscle modulates the phenotype of severe SMA mice","volume":"20","author":"Bosch-Marc\u00e9","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2014.84_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1089\/hum.2010.114","article-title":"Combination of SMN trans-splicing and a neurotrophic factor increases the life span and body mass in a severe model of spinal muscular atrophy","volume":"22","author":"Shababi","year":"2011","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2014.84_bib11","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.2119\/molmed.2012.00056","article-title":"IPLEX administration improves motor neuron survival and ameliorates motor functions in a severe mouse model of spinal muscular atrophy","volume":"18","author":"Murdocca","year":"2012","journal-title":"Mol Med"},{"key":"10.1038\/mt.2014.84_bib12","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.nbd.2011.06.021","article-title":"IGF-1 delivery to CNS attenuates motor neuron cell death but does not improve motor function in type III SMA mice","volume":"45","author":"Tsai","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1038\/mt.2014.84_bib13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.nmd.2013.10.011","article-title":"Somatropin treatment of spinal muscular atrophy: a placebo-controlled, double-blind crossover pilto study","volume":"24","author":"Kirschner","year":"2013","journal-title":"Neuromuscular Dis"},{"key":"10.1038\/mt.2014.84_bib14","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1083\/jcb.152.5.1107","article-title":"Deletion of murine SMN exon 7 directed to skeletal muscle leads to severe muscular dystrophy","volume":"152","author":"Cifuentes-Diaz","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1038\/mt.2014.84_bib15","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/jmg.2008.057950","article-title":"Congenital heart disease is a feature of severe infantile spinal muscular atrophy","volume":"45","author":"Rudnik-Sch\u00f6neborn","year":"2008","journal-title":"J Med Genet"},{"key":"10.1038\/mt.2014.84_bib16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature10485","article-title":"Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model","volume":"478","author":"Hua","year":"2011","journal-title":"Nature"},{"key":"10.1038\/mt.2014.84_bib17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuropharm.2012.06.024","article-title":"Gene therapy and neurodevelopmental disorders","volume":"68","author":"Gray","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1038\/mt.2014.84_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yexcr.2004.03.022","article-title":"The SMN complex","volume":"296","author":"Gubitz","year":"2004","journal-title":"Exp Cell Res"},{"key":"10.1038\/mt.2014.84_bib19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJM199702273360907","article-title":"Insulin-like growth factors","volume":"336","author":"Roith","year":"1997","journal-title":"N Eng J Med"},{"key":"10.1038\/mt.2014.84_bib20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1741-7015-11-38","article-title":"Sodium vanadate combined with L-ascorbic acid delays disease progression, enhances motor performance, and ameliorates muscle atrophy and weakness in mice with spinal muscular atrophy","volume":"11","author":"Liu","year":"2013","journal-title":"BMC Med"},{"key":"10.1038\/mt.2014.84_bib21","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/mt.2008.60","article-title":"Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity","volume":"16","author":"Dodge","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2014.84_bib22","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1038\/mt.2010.206","article-title":"AAV4-mediated expression of IGF-1 and VEGF within cellular components of the ventricular system improves survival outcome in familial ALS mice","volume":"18","author":"Dodge","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2014.84_bib23","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1093\/hmg\/ddr126","article-title":"Muscle-specific expression of insulin-like growth factor 1 improves outcome in Lama2Dy-w mice, a model for congenital muscular dystrophy type 1A","volume":"20","author":"Kumar","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2014.84_bib24","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/01.RES.83.5.516","article-title":"Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I","volume":"83","author":"Wang","year":"1998","journal-title":"Circ Res"},{"key":"10.1038\/mt.2014.84_bib25","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1523\/JNEUROSCI.20-08-02926.2000","article-title":"Circulating insulin-like growth factor I mediates effects of exercise on the brain","volume":"20","author":"Carro","year":"2000","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2014.84_bib26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0955-2235(95)00003-8","article-title":"Pharmacokinetics and bioavailability of rhIGF-I\/IGFBP-3 in the rat and monkey","volume":"6","author":"Adams","year":"1995","journal-title":"Prog Growth Factor Res"},{"key":"10.1038\/mt.2014.84_bib27","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/hmg\/ddr600","article-title":"A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse","volume":"21","author":"Porensky","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2014.84_bib28","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1101\/gad.7.12b.2609","article-title":"IGF-I is required for normal embryonic growth in mice","volume":"7","author":"Powell-Braxton","year":"1993","journal-title":"Genes Dev"},{"key":"10.1038\/mt.2014.84_bib29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/71709","article-title":"A mouse model for spinal muscular atrophy","volume":"24","author":"Hsieh-Li","year":"2000","journal-title":"Nat Genet"},{"key":"10.1038\/mt.2014.84_bib30","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.nbd.2006.07.004","article-title":"Establishing a standardized therapeutic testing protocol for spinal muscular atrophy","volume":"24","author":"Tsai","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1038\/mt.2014.84_bib31","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/0031-9384(86)90058-2","article-title":"Use of hypothermia for general anesthesia in preweanling rodents","volume":"38","author":"Phifer","year":"1986","journal-title":"Physiol Behav"},{"key":"10.1038\/mt.2014.84_bib32","first-page":"1.6.1","article-title":"Use of mouse, rat, hamster, and rabbit","author":"Donovan","year":"2006","journal-title":"Curr Protocol Immunol"},{"key":"10.1038\/mt.2014.84_bib33","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jpeds.2008.08.050","article-title":"Correlation of survival motor neuron expression in leukocytes and spinal cord in spinal muscular atrophy","volume":"154","author":"Tsai","year":"2009","journal-title":"J Pediatr"},{"key":"10.1038\/mt.2014.84_bib34","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00109-008-0388-1","article-title":"Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice","volume":"86","author":"Tsai","year":"2008","journal-title":"J Mol Med"},{"key":"10.1038\/mt.2014.84_bib35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.nbd.2007.04.009","article-title":"Abnormal motor phenotype in the SMN\u03947 mouse model of spinal muscular atrophy","volume":"27","author":"Butchbach","year":"2007","journal-title":"Neurobiol Dis"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616307420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616307420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T07:08:32Z","timestamp":1565420912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616307420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1525001616307420"],"URL":"https:\/\/doi.org\/10.1038\/mt.2014.84","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718383237.793502443","asserted-by":"object"}]},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}